Iboga and ibogaine

Tabernanthe iboga is a shrub endemic to Central Africa that is traditionally part of rites of passage and healing ceremonies among Bwiti communities. In the 1960s its application in the treatment of substance use disorder led to the development of a medical subculture and research into clinical applications.

ICEERS is conducting the first-ever registered clinical trial on ibogaine and opioid dependency in a pioneering harm-reduction treatment center in Catalonia that allows real-world patient participation. In parallel, we have been working to ensure the globalization of ibogaine happens in a way that strengthens local communities in Gabon through right relationship and benefit sharing.

The Iboga and Ibogaine Community Engagement Initiative

This initiative engaged with the global community to crowdsource opinions and ideas about what an ideal future looks like for iboga and ibogaine in global society.

We conducted the initiative in two phases and published reports following each phase, sharing visions from the communities we engaged with and findings that provided insights into the current state of iboga and ibogaine practices, as well as opportunities and challenges.

A final report outlines conclusions and recommendations, charting a path forward for the future of iboga and ibogaine. We encourage all those interested in or engaged in practices with iboga or ibogaine to read this report, discuss with your community, and determine how you can takes steps to be a part of a brighter future for this sacred plant medicine.

In 2020, ICEERS launched the first-ever Phase II clinical trial examining the efficacy of ibogaine for opioid dependence and detox from methadone.